SEI INVESTMENTS CO - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$290,613
+2.0%
335,0000.0%0.00%
Q2 2023$285,051
+82.6%
335,000
+82.1%
0.00%
Q1 2023$156,121
+2.7%
184,0000.0%0.00%
Q4 2022$152,039
+4.1%
184,0000.0%0.00%
Q3 2022$146,000
+82.5%
184,000
+80.4%
0.00%
Q2 2022$80,000
-5.9%
102,0000.0%0.00%
Q1 2022$85,000102,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 48,416$41,563,0002.83%
HPS Investment Partners, LLC 5,419$4,567,0001.76%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,169,0000.83%
ADVENT CAPITAL MANAGEMENT /DE/ 48,979,000$41,243,0000.66%
Aequim Alternative Investments LP 20,500,000$17,276,0000.46%
Kohlberg Kravis Roberts & Co. L.P. 45,394,000$38,255,0000.35%
Quaero Capital S.A. 900,000$757,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 21,614,000$18,214,0000.19%
Brandywine Global Investment Management, LLC 29,515,000$24,873,0000.18%
AVIVA PLC 38,300,000$32,126,0000.16%
View complete list of HAEMONETICS CORP MASS shareholders